Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Publication Category: Metabolic Health

Limited Impact of Fetal Sex and Maternal Body Mass Index on Fetal and Maternal Insulin Resistance and Lipid Metabolism: Findings from the PEARs Study

A. R. Rafferty; A. A. Geraghty; M. A. Kennelly; E. C. O'Brien; R. M. Reji; J. Mehegan; R. Segurado; T. Smith; O. Maguire; M. Cronin; F. M. McAuliffe Limited Impact of Fetal Sex and Maternal Body Mass Index on Fetal and Maternal Insulin Resistance and Lipid Metabolism: Findings from the PEARs Study Reprod Sci
Cholesterol Insulin Resistance & Diabetes

Maternal obesity and dyslipidemia associated with gestational diabetes mellitus (GDM)

E. G. O'Malley; C. M. E. Reynolds; A. Killalea; R. O'Kelly; S. R. Sheehan; M. J. Turner Maternal obesity and dyslipidemia associated with gestational diabetes mellitus (GDM) Eur J Obstet Gynecol Reprod Biol
Cholesterol Insulin Resistance & Diabetes

Timing of screening for gestational diabetes mellitus in women with moderate and severe obesity

V. O'Dwyer; N. Farah; J. Hogan; N. O'Connor; M. M. Kennelly; M. J. Turner Timing of screening for gestational diabetes mellitus in women with moderate and severe obesity Acta Obstet Gynecol Scand
Insulin Resistance & Diabetes

Risk factors for hyperglycemia in pregnancy in the DALI study differ by period of pregnancy and OGTT time point

L. C. Mendoza; J. Harreiter; D. Simmons; G. Desoye; J. M. Adelantado; F. Juarez; A. Chico; R. Devlieger; A. van Assche; S. Galjaard; P. Damm; E. R. Mathiesen; D. M. Jensen; L. L. T. Andersen; M. Tanvig; A. Lapolla; M. G. Dalfra; A. Bertolotto; U. Mantaj; Risk factors for hyperglycemia in pregnancy in the DALI study differ by period of pregnancy and OGTT time point Eur J Endocrinol
Insulin Resistance & Diabetes

Melatonin Action on the Activity of Phagocytes from the Colostrum of Obese Women

T. C. Morais; A. C. Honorio-França; M. Fujimori; O. B. de Quental; R. S. Pessoa; E. L. França; L. C. de Abreu Melatonin Action on the Activity of Phagocytes from the Colostrum of Obese Women Medicina (Kaunas)

Plasma Glycated CD59 Predicts Early Gestational Diabetes and Large for Gestational Age Newborns

D. Ma; M. A. Luque-Fernandez; D. Bogdanet; G. Desoye; F. Dunne; J. A. Halperin Plasma Glycated CD59 Predicts Early Gestational Diabetes and Large for Gestational Age Newborns J Clin Endocrinol Metab
Insulin Resistance & Diabetes

Risks associated with obesity in pregnancy, for the mother and baby: a systematic review of reviews

J. Marchi; M. Berg; A. Dencker; E. K. Olander; C. Begley Risks associated with obesity in pregnancy, for the mother and baby: a systematic review of reviews Obes Rev

A randomized controlled trial of probiotics to reduce maternal glycaemia in obese pregnancy

K. Lindsay; O. Maguire; T. Smith; L. Brennan; F. McAuliffe A randomized controlled trial of probiotics to reduce maternal glycaemia in obese pregnancy American journal of obstetrics and gynecology
Cholesterol Insulin Resistance & Diabetes

Gestational weight gain in obese pregnancy: impact on maternal and foetal metabolic parameters and birthweight

K. L. Lindsay; L. Brennan; A. Rath; O. C. Maguire; T. Smith; F. M. McAuliffe Gestational weight gain in obese pregnancy: impact on maternal and foetal metabolic parameters and birthweight J Obstet Gynaecol

Probiotics in obese pregnancy do not reduce maternal fasting glucose: a double-blind, placebo-controlled, randomized trial (Probiotics in Pregnancy Study)

K. L. Lindsay; M. Kennelly; M. Culliton; T. Smith; O. C. Maguire; F. Shanahan; L. Brennan; F. M. McAuliffe Probiotics in obese pregnancy do not reduce maternal fasting glucose: a double-blind, placebo-controlled, randomized trial (Probiotics in Pregnancy Study) American journal of clinical nutrition
Insulin Resistance & Diabetes

Older posts

Newer posts

← Previous Page1 … Page30 Page31 Page32 … Page54 Next →

Search for:

Recent Posts

9th ASOI Annual Conference – Registration now open!
Press Release for World Obesity Day 4th March 2024
ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO
ECO 2023 sponsorship update

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Privacy Policy
Site Map

©2025 ASOI